Stroke treatment study
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial is studying treatments for stroke using a flexible platform that can test multiple therapies at once. It aims to find better ways to help people who have had a stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older
- You must have been diagnosed with a stroke
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing different treatments for stroke patients to find which work best. It's designed to adapt over time so new treatments can be added as research progresses.
This trial tests whether a new tablet (Y-6) given under the tongue can improve recovery after a severe stroke caused by a blocked large blood vessel in the brain. The study is for people who are already scheduled to have a procedure to remove the blockage.
This study is collecting information on stroke patients who received the clot-dissolving drug tenecteplase. It aims to see how well the drug works and how safe it is in everyday hospital care in China.
This trial tests whether a traditional Chinese medicine (Angong Niuhuang pill) made from different sources of a natural ingredient can help people who recently had a moderate stroke caused by a blood clot. It aims to see if the pill can improve recovery.
This study tests a treatment for stroke given soon after symptoms start. It aims to improve recovery by using a medication to dissolve blood clots.
This study tests a traditional Chinese herb formula called Qingre Huatan to see if it can stop stroke symptoms from getting worse in the first few days. It is for people who have had an ischemic stroke within the last 48 hours and are at high risk for early decline.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.